Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and December 2016

Showing 1 to 10 of 312
Title Reference number Published Last updated
Nivolumab for previously treated advanced renal cell carcinoma Reference number:TA417 TA00417 Published:November 2016 20161101 Last updated:November 2016 20161123
Dapagliflozin in triple therapy for treating type 2 diabetes Reference number:TA418 TA00418 Published:November 2016 20161101 Last updated:November 2016 20161123
Apremilast for treating moderate to severe plaque psoriasis Reference number:TA419 TA00419 Published:November 2016 20161101 Last updated:November 2016 20161123
Dapagliflozin in combination therapy for treating type 2 diabetes Reference number:TA288 TA00288 Published:June 2013 20130601 Last updated:November 2016 20161123
Elbasvir–grazoprevir for treating chronic hepatitis C Reference number:TA413 TA00413 Published:October 2016 20161001 Last updated:October 2016 20161026
Cobimetinib in combination with vemurafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma Reference number:TA414 TA00414 Published:October 2016 20161001 Last updated:October 2016 20161026
Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitor Reference number:TA415 TA00415 Published:October 2016 20161001 Last updated:October 2016 20161026
Osimertinib for treating locally advanced or metastatic EGFR T790M mutation-positive non-small-cell lung cancer Reference number:TA416 TA00416 Published:October 2016 20161001 Last updated:October 2016 20161026
Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer Reference number:TA406 TA00406 Published:September 2016 20160901 Last updated:September 2016 20160928
Secukinumab for active ankylosing spondylitis after treatment with non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors Reference number:TA407 TA00407 Published:September 2016 20160901 Last updated:September 2016 20160928